Involvement of intrinsic cholinergic and GABAergic innervation in the effect of NMDA on striatal dopamine efflux and metabolism as assessed by microdialysis studies in freely moving rats

European Journal of Neuroscience

Volumn 14, Issue 5, 2001, Pages 851-860

  Whitehead, K J ^a,b   Rose, S ^a   Jenner, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

(+) bicuculline; Acetylcholine; Atropine; GABA; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ATROPINE; BICUCULLINE; DOPAMINE; HOMOVANILLIC ACID; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TETRODOTOXIN; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ACETYLCHOLINE; AMINO ACID RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; N METHYLASPARTIC ACID;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINE RELEASE; DRUG EFFECT; FACILITATION; GABAERGIC SYSTEM; MALE; METABOLITE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PARASYMPATHETIC INNERVATION; PERFUSION; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN LEVEL; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY;

3,4-DIHYDROXYPHENYLACETIC ACID; ACETYLCHOLINE; ANIMALS; ATROPINE; BICUCULLINE; BRAIN CHEMISTRY; CORPUS STRIATUM; DOPAMINE; EXCITATORY AMINO ACID AGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HOMOVANILLIC ACID; MICRODIALYSIS; MOTOR ACTIVITY; N-METHYLASPARTATE; PARASYMPATHOLYTICS; RATS; TETRODOTOXIN;

EID: 0036421309     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0953-816x.2001.01702.x     Document Type: Article

References (70)

1. Albin, R.L., Makowiec, R.L., Hollingsworth, Z.R., Dure, L.S., Penney, J.B. & Young, A.B. (1992) Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study. Neuroscience, 46, 35-48.
2. Anderson, J.J., Kuo, S. & Chase, T.N. (1994) Endogenous excitatory amino acids tonically stimulate striatal acetylcholine release through NMDA but not AMPA receptors. Neurosci. Lett., 176, 264-268.
3. Arbuthnott, G.W., Fairbrother, I.S. & Butcher, S.P. (1990) Dopamine release and metabolism in the rat striatum: An analysis by 'in vivo' brain microdialysis. Pharmac. Ther., 48, 281-293.
4. Bolam, J.P. (1984) Synapses of identified neurons in the neostriatum. In Evered, D. & O'Connor, M. (eds), Functions of the Basal Ganglia. Pitman, London, pp. 30-47.
5. Bouyer, J.J., Park, D.H., Joh, T.H. & Pickel, V.M. (1984) Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in the neostriatum. Brain Res., 302, 267-275.
6. Campochiaro, P., Schwarcz, R. & Coyle, J.T. (1977) GABA receptor binding in rat striatum: Localization and effects of denervation. Brain Res., 136, 501-511.
7. Carter, C.J., L'Heureux, R. & Scatton, B. (1988) Differential control by N-methyl-D-aspartate and kainate of striatal dopamine release in vivo: A trans-striatal dialysis study. J. Neurochem., 51, 462-468.
8. Chang, R.S., Tran, V.T. & Snyder, S.H. (1980) Neurotransmitter receptor localizations: Brain lesion induced alterations in benzodiazepine, GABA, beta-adrenergic and histamine H1-receptor binding. Brain Res., 190, 95-110.
9. Chéramy, A., Desce, J.M., Godeheu, G., Galli, T. & Glowinski, J. (1993) Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomes. J. Neurochem., 61 (Suppl.), S252C.
10. Chowdhury, M. & Fillenz, M. (1991) Presynaptic adenosine A2 and N-methyl-D-aspartate receptors regulate dopamine synthesis in rat striatal synaptosomes. J. Neurochem., 56, 1783-1788.
11. Damsma, G., Westerink, B.H.C., de Vries, J.B. & Horn, A.S. (1988) The effect of systemically applied cholinergic drugs on the striatal release of dopamine and its metabolites, as determined by automated brain dialysis in conscious rats. Neurosci. Lett., 89, 349-354.
12. Dawson, T.M., Dawson, V.L., Gage, F.H., Fisher, L.J., Hunt, A.A. & Wamsley, J.K. (1991) Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral dopamine pathway with 6-hydroxydopamine (6-OHDA): Normalization by fetal mesencephalic transplants. Brain Res., 540, 145-152.
13. De Belleroche, J. & Bradford, H.F. (1978) Biochemical evidence for the presence of presynaptic receptors on dopaminergic nerve terminals. Brain Res., 142, 53-68.
14. De Boer, P. & Westerink, B.H.C. (1994) GABAergic modulation of striatal cholinergic interneurons: An in vivo microdialysis study. J. Neurochem., 62, 70-75.
15. De Klippel, N., Sarre, S., Ebinger, G. & Michotte, Y. (1993) Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: An in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats. Brain Res., 630, 57-64.
16. Desce, J.M., Godeheu, G., Galli, T., Glowinski, J. & Chéramy, A. (1994) Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes. Brain Res., 640, 205-214.
17. Desce, J.M., Godehieu, G., Galli, T., Artaud, F., Cheramy, A. & Glowinski, J. (1992) L-glutamate-evoked release of dopamine from synaptosomes of the rat striatum: Involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience, 47, 333-339.
18. +-induced depolarization and/or forskolin in rat striatal slices. J. Neurochem., 45, 173-184.
19. Freund, T., Powell, J. & Smith, A. (1984) Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons with particular reference to dendritic spines. Neuroscience, 13, 1189-1215.
20. 3H]GABA in striosome- and matrix-enriched areas of the rat striatum. Brain Res., 649, 243-252.
21. Giorguieff, M.F., Le Floc'h, M.L., Glowinski, J. & Besson, M.J. (1977) Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat. J. Pharmacol. Exp. Ther., 200, 535-544.
22. Goyal, R.K. (1989) Muscarinic receptor subtypes. Physiology and clinical implications. New Eng. J. Med., 321, 1022-1029.
23. Grace, A.A. (1991) Phasic versus tonic dopamine release and the modulation of dopamine system reponsivity: A hypothesis for the etiology of schizophrenia. Neuroscience, 41, 1-24.
24. Greenamyre, J.T. & O'Brien, C.F. (1991) N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease. Arch. Neurol., 48, 977-981.
25. Groves, P.M. (1980) Synaptic endings and their postsynaptic targets in neostriatum: Synaptic specializations revealed from analysis of serial sections. Proc. Natl. Acad. Sci. USA, 77, 6926-6929.
26. Hurd, Y.L. & Ungerstedt, U. (1989) In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur. J. Pharmacol., 166, 251-260.
27. Imperato, A., Scrocco, M.G., Bacchi, S. & Angelucci, L. (1990) NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur. J. Pharmacol., 187, 555-556.
28. Johnson, K.M. & Jeng, Y.-J. (1991) Pharmacological evidence for N-methyl-D-aspartate receptors on nigrostriatal dopaminergic nerve terminals. Can. J. Physiol. Pharmacol., 69, 1416-1421.
29. Keefe, K.A., Zigmond, M.J. & Abercrombie, E.D. (1992) Extracellular dopamine in striatum: Influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience, 47, 325-332.
30. Kemel, M.-L., Desban, M., Glowinski, J. & Gauchy, C. (1989) Distinct presynaptic control of dopamine release in striosomal and matrix areas of the cat caudate nucleus. Proc. Natl. Acad. Sci. USA, 86, 9006-9010.
31. Kemp, J.M. & Powell, T.P.S. (1971) The site of termination of afferent fibres in the caudate nucleus. Phil. Trans. R. Soc. Lond., B., 262, 413-427.
32. Kischka, U., Farber, S.A., Marshall, D. & Wurtman, R.J. (1993) Carbachol and naloxone synergistically elevate dopamine release in rat striatum: An in vivo microdialysis study. Brain Res., 613, 288-290.
33. Kito, S., Shimonyama, M. & Arakawa, R. (1986) Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites. Jpn. J. Pharmacol., 40, 57-67.
34. König, J.F.R. & Klippel, R.A. (1963) The Rat Brain: A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem. Williams & Wilkens, Baltimore, MD.
35. Kornhuber, J. & Kornhuber, M.E. (1986) Presynaptic dopaminergic modulation of cortical input to the striatum. Life Sci., 39, 669-674.
36. Krebs, M.O., Desce, J.M., Kemel, M.L., Gauchy, C., Godeheu, G., Chéramy, A. & Glowinski, J. (1991) Glutamatergic control of dopamine release in the rat striatum: Evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem., 56, 81-85.
37. Krebs, M.O., Kemel, M.L., Gauchy, C., Desban, M. & Glowinski, J. (1993) Local GABAergic regulation of the N-methyl-D-aspartate-evoked release of dopamine is more prominent in striosomes than in matrix of the rat striatum. Neuroscience, 57, 249-260.
38. Lapper, S.R. & Bolam, J.P. (1992) Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat. Neuroscience, 51, 533-545.
39. 3H]dopamine release in vitro by endogenous acetylcholine. Brain Res., 248, 61-69.
40. Levi, G. & Raiteri, M. (1993) Carrier-mediated release of neurotransmitters. Trends Neurosci., 16, 415-419.
41. Leviel, V., Gobert, A. & Guibert, B. (1990) The glutamate-mediated release of dopamine in the rat striatum: Further characterization of the dual excitatory-inhibitory function. Neuroscience, 39, 305-312.
42. Martínez-Fong, D., Rosales, M.G., Góngora-Alfaro, J.L., Hernández, S. & Aceves, J. (1992) NMDA receptor mediates dopamine release in the striatum of unanaesthetised rats as measured by brain microdialysis. Brain Res., 595, 309-315.
43. 2+ in mammalian neurons. In Lodge, D. & Collingridge, G. (eds), The Pharmacology of Excitatory Amino Acids. Trends in Pharmacological Science Special Report. Elsevier Trends Journals, Cambridge, UK, pp. 36-42.
44. Meredith, G.E. & Wouterlood, F.G. (1990) Hippocampal and midline thalamic fibers and terminals in relation to the choline acetyltransferase-immunoreactive neurons in nucleus accumbens of the rat: A light and electron microscopic study. J. Comp. Neurol., 296, 204-221.
45. Moghaddam, B. & Bolinao, M.L. (1994) Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase levels of dopamine: Implications for tonic influence of glutamate on dopamine release. Synapse, 18, 337-342.
46. Moghaddam, B. & Gruen, R.J. (1991) Do endogenous excitatory amino acids influence striatal dopamine release? Brain Res., 544, 329-330.
47. Morari, M., Marti, M., Sbrenna, S., Fuxe, K., Bianchi, C. & Beani, L. (1998) Reciprocal dopamine-glutamate modulation of release in the basal ganglia. Neurochem. Int., 33, 383-397.
48. Morari, M., O'Connor, W.T., Ungerstedt, U., Bianchi, C. & Fuxe, K. (1996) Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat-II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function. Neuroscience, 72, 89-97.
49. Morari, M., O'Connor, W.T., Ungerstedt, U. & Fuxe, K. (1993) N-methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthetized rat: An in vivo microdialysis study. J. Neurochem., 60, 1884-1893.
50. O'Connor, W.T., Drew, K.L. & Ungerstedt, U. (1995) Differential cholinergic regulation of dopamine release in the dorsal and ventral neostriatum of the rat: An in vivo microdialysis study. J. Neurosci., 15, 8353-8361.
51. Pickel, V.M., Beckley, S.C., Joh, T.H. & Reis, D.J. (1981) Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum. Brain Res., 225, 373-385.
52. Pickel, V.M. & Chan, J. (1990) Spiny neurons lacking choline acetyltransferase immunoreactivity are major targets of cholinergic and cholaminergic terminals in rat striatum. J. Neurosci. Res., 25, 263-280.
53. Pin, P.P., Van-Vliet, B.J. & Bockaert, J. (1988) NMDA and kainate-evoked GABA release from striatal neurones differentiated in primary culture: Differential blocking by phencyclidine. Neurosci. Lett., 87, 87-92.
54. Potter, L.J., Flynn, D.D., Hanchett, H.E., Kalinoski, D.L., Luber-Narod, J. & Mash, D.C. (1984) Independent M1 and M2 receptors, ligands, autoradiography and function. Trends Pharmacol. Sci., 5 (Suppl.), 22-31.
55. A receptors modulate dopamine release from rat striatal synaptosomes. J. Neurochem., 61, 1634-1639.
56. Smolders, I., De Klippel, N., Sarre, S., Ebinger, G. & Michotte, Y. (1995) Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat. Eur. J. Pharmacol., 284, 83-91.
57. Snell, L.D. & Johnson, K.M. (1986) Characterisation of the inhibition of excitatory amino acid-induced neurotransmitter release in the striatum by phencyclidine-like drugs. J. Pharmacol. Exp. Ther., 238, 938-946.
58. Starr, M.S. (1995) Antiparkinsonian actions of glutamate antagonists- alone and with L-DOPA: A review of evidence and suggestions for possible mechanisms. J. Neural. Transm. Park. Dis. Demen. Sect., 10, 141-185.
59. Tallaksen-Greene, S.J., Wiley, S.J. & Albin, R.L. (1992) Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons. Brain Res., 594, 165-170.
60. Ulus, I.H., Buyukuysal, R.L. & Wurtman, R.J. (1992) N-methyl-D-aspartate increases acetylcholine release from rat striatum and cortex: Its effect is augmented by choline. J. Pharmacol. Exp. Ther., 261, 1122-1128.
61. 3H]γ-aminobutyric acid from striatal neurons in primary culture. J. Neurochem., 51, 435-441.
62. Westerink, B.H.C., de Boer, P., Santiago, M. & De Vries, J.B. (1994) Do nerve terminals and cell bodies of the nigrostriatal dopaminergic neurons of the rat contain similar receptors? Neurosci. Lett., 167, 109-112.
63. Westerink, B.H.C., Santiago, M. & De Vries, J.B. (1992) The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat. NS Arch. Pharmacol., 345, 523-529.
64. Whitehead, K.J., Rose, S., Hindmarsh, J.G., Jenner, P. & Marsden, C.D. (1992) A novel design for an inexpensive microdialysis probe for direct stereotaxic implantation into the striatum of the rat. Br. J. Pharmacol., 106, 140P.
65. Wüllner, U., Testa, C.M., Catania, M.V., Young, A.B. & Penney, J.B. (1994) Glutamate receptors in striatum and substantia nigra: Effects of medial forebrain bundle lesions. Brain Res., 645, 98-102.
66. Xu, M., Mizobe, F., Yamamoto, T. & Kato, T. (1989) Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats. Brain Res., 495, 232-242.
67. Young, A.M.J. & Bradford, H.F. (1993) N-Methyl-D-aspartate releases γ-aminobutyric acid from rat striatum in vivo: A microdialysis study using a novel preloading method. J. Neurochem., 60, 487-492.
68. 3H]kainate binding in rat caudate-putamen and nucleus accumbens after 6-hydroxydopamine lesions of the medial forebrain bundle: An autoradiographic study. Brain Res., 731, 132-140.
69. Zetterström, T., Sharp, T., Collin, A.K. & Ungerstedt, U. (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol., 148, 327-334.
70. Zigmond, R.E., Schwarzschild, M.A. & Rittenhouse, A.R. (1989) Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu. Rev. Neurosci., 12, 415-461.